Mamaling, Policarpio, JR.. I.

HRN: 07-17-18  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/06/2025
05/12/2025
IV
500mg
Q8
Amoebiasis
Waiting Final Action 
05/06/2025
METRONIDAZOLE 500MG (TAB)
05/06/2025
05/12/2025
PO
1 1/2tab
TID
AGE Sec To Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: